Objective: Microvascular brain injury (mVBI) is a common pathological correlate of vascular contributions to cognitive impairment and dementia (VCID) that leads to white matter (WM) injury (WMI). VCID appears to arise from chronic recurrent white matter ischemia that triggers oxidative stress and an increase in total oligodendrocyte lineage cells. We hypothesized that mVBI involves vasodilator dysfunction of white matter penetrating arterioles and aberrant oligodendrocyte progenitor cell (OPC) responses to WMI. Methods: We analyzed cases of mVBI with low Alzheimer's disease neuropathological change in prefrontal cortex WM from rapid autopsies in a population-based cohort where VCID frequently occurs. Arteriolar vasodilator function was quantified by videomicroscopy. OPC maturation was quantified using lineage specific markers. Results: Acetylcholine-mediated arteriolar dilation in mVBI was significantly reduced in WM penetrators relative to pial arterioles. Astrogliosis-defined WMI was positively associated with increased OPCs and was negatively associated with decreased mature oligodendrocytes. Interpretation: Selectively impaired vasodilator function of WM penetrating arterioles in mVBI occurs in association with aberrant differentiation of OPCs in WMI, which supports that myelination disturbances in VCID are related to disrupted maturation of myelinating oligodendrocytes. ANN NEUROL 2018;83:142-152 V ascular contributions to cognitive impairment and dementia (VCID) are highly prevalent in the elderly and detected in over 85% of cognitively normal individuals aged 75 years.
V ascular contributions to cognitive impairment and dementia (VCID) are highly prevalent in the elderly and detected in over 85% of cognitively normal individuals aged 75 years. 1, 2 VCID is accompanied by microvascular brain injury (mVBI), which comprises a spectrum of subcortical small vessel disease that contributes to progressive periventricular and frontal white matter (WM) injury (WMI) 3, 4 and impairment in cognitive and executive function. [5] [6] [7] WMI appears related to microvascular disturbances that reduce cerebral perfusion. However, postmortem human and murine physiological studies were limited mostly to the middle cerebral artery [8] [9] [10] [11] and pial microvessels. 12 Consistent with microvascular dysfunction in VCID, we identified significant oxidative damage to myelin and axons in mVBI independent of Alzheimer's disease (AD) pathology. 13 Oxidative damage coincided with extracellular matrix disruption and increased oligodendrocyte (OL) lineage cells. Although strong associations between oxidative stress and WMI in chronic hypertension and diabetes support a microvascular etiology in VCID, 1, 14 the role of microvascular dysfunction in myelination failure in VCID remains undefined. We hypothesized that vasomotor dysfunction of WM-penetrating arterioles triggers WMI that results in a functionally dysmature injury response where OPCs proliferate, but fail to terminally differentiate to myelinating OLs. We restricted our study to a unique cohort of relatively uncommon cases of mVBI with low AD pathology and exclusion of other commonly comorbid pathological changes associated with brain aging. We analyzed frontal WM of older adults, obtained by rapid autopsy from a population-based cohort. In contrast to pial arterioles, vasodilation of WM penetrating arterioles was selectively impaired in mVBI cases with WMI. WMI involved a significant increase in OPCs and a reduction in mature myelinating OLs. Thus, selective vasodilator dysfunction of WM penetrating arterioles appears to contribute to remyelination failure that involves arrested maturation of OPCs that fail to generate myelinating OLs in chronic WMI.
Materials and Methods

Subjects and Tissue Handling
All specimens were donated by participants in the Adult Changes in Thought (ACT) study, an ongoing populationbased study of aging and incident dementia among men and women in Seattle, Washington. 13 For vascular reactivity studies, between 2013 and 2016, we prospectively collected 38 human WM samples at the level of prefrontal cortex (PFOC) by rapid autopsy in the University of Washington Neuropathology Core. 13 From the 38 prospective cases, we identified 5 no VBI cases and 8 with mVBI. For OL maturational studies, we retrospectively analyzed 36 WM samples from PFOC 13 of cases with or without mVBI collected between 2007 and 2013. 13 Demographic/autopsy data for these cohorts is indicated in Tables 1 and 2 . Neuropathological examination of autopsied brains was performed as described with postmortem interval <8 hours. 13, 15 Cases were identified with mVBI and excluded other commonly comorbid pathological changes in the aging brain, including Lewy body disease and gross infarcts or hemorrhages. Inclusion criteria for vascular reactivity studies took into consideration the impact of vascular and parenchymal amyloid and employed the NIA-AA (National Institute on Aging-Alzheimer's Association) criteria and scoring for cerebral amyloid angiopathy (CAA) by evaluation of amyloid b immunohistochemistry in leptomeningeal and parenchymal vessels. Cases with intermediate or high NIA-AA scores for amyloid b plaques were excluded. Because the OL maturational studies included many cases that preceded the NIA-AA criteria, we utilized Braak scoring of neurofibrillary degeneration as used in our past studies. 13, 16 For both cohorts, cases with cortical, WM, basal After 1-hour equilibration, internal arteriolar diameter (ID) was measured in response to step increases in intraluminal pressure from 20 to 120mm Hg (20mm Hg pressure increments) in the presence of normal Ca 21 (1.25mM) 100)]. Arterioles responding with >50% dilation to the highest concentrations of either ACh or histamine were analyzed. Inclusion criteria for vessel viability were >50% vasoconstriction to U46619 (10 27 mol/l) and >50% vasodilation either to the pharmacological agonists (to 10 26 mol/l) ACh, SNP, or histamine. Of the 38 cases studied, 34 pial and 25 WM arterioles met these inclusion criteria. Of the identified 20 cases with low AD pathology, 3 additional cases with no VBI and 4 with mVBI were excluded, because either the pial or the WMpenetrating vessels were not viable in that particular specimen.
Validation of Functional Assessment of Postmortem Human Arterioles
To validate our rapid human autopsy-vascular protocol, we assessed with institutional animal care and use committee approval vasoreactivity and viability of postmortem adult male Wistar rat cerebral arteries handled similarly to human vessels. After death, rats were kept at room temperature for 3 hours. Thereafter, brains were stored overnight in aCSF at 48 C, after which vasoreactivity of middle cerebral artery branches (MCAs) was assessed. MCA vasoreactivity was also analyzed immediately after death and at 3 hours postmortem.
Immunohistochemistry
After antigen retrieval, 16 
Results
Selectively impaired WM-arteriole dilation in mVBI
We determined whether human WM arterioles displayed vascular reactivity differences relative to pial arterioles in mVBI. To validate our approach, we analyzed adult rodent vessels subjected to autopsy conditions similar to human vessels. Figure 1 demonstrates preserved vasodilation to ACh in rat MCA segments isolated immediately (Fig 1A) , at 3 hours postmortem or under conditions similar to human vessels (Fig 1B) . Vasodilation of rat vessels to ACh and histamine (not shown) did not differ significantly from control human WM arterioles (Fig 1C) . We analyzed brains from individuals with or without mVBI, but no macroscopic infarcts or hemorrhages and no or low levels of commonly comorbid neuropathological changes observed in older individuals. From 38 prospective cases, we identified mVBI (n 5 8) and controls (no VBI; n 5 5) with our pathological and vascular viability inclusion criteria (Methods and (Fig 2A) , SNP ( Fig  2B) , and histamine ( Fig 2C) were similar in pial arterioles in no VBI and mVBI groups. However, dilation of WM arterioles to increasing concentrations of ACh was significantly reduced in the mVBI group (Fig 2A) . Response to SNP was also reduced, but did not reach significance (p 5 0.109; Fig 2B) , whereas histamine-induced dilation was similar in both groups (Fig 2C) . There was no association between pial and WM vasodilation responses to ACh and SNP and a weak association in response to histamine, which suggested that selectively impaired vasodilation to ACh is an intrinsic abnormality of WM arterioles. Arteriole responses to ACh were not significantly influenced by patient age or postmortem interval.
We next determined whether the mVBI cohort that displayed selective WM-arteriolar dysfunction also displayed increased WMI. To estimate WMI, we quantified GFAP-labeled astrocytes in prefrontal WM (Fig 3A,B) . We found a trend toward a significant increase in astrocyte density for mVBI versus no VBI ( Fig. 3C ; p 5 0.077; two tailed Student's t test with Welch's correction).
WMI in mVBI Triggers Astrogliosis and Microgliosis
Given that WM arteriolar dysfunction appeared to associate with increased WMI, we analyzed prefrontal WM in a separate retrospective cohort of 36 cases with mVBI (n 5 21) or no VBI (n 5 15; Table 2 ). We hypothesized that WMI in mVBI is related to aberrant OPC maturation. We confirmed increased WMI in mVBI cases by quantifying GFAP-labeled astrocytes (Fig 4A-C) or Iba-1-labeled microglia (Fig 4D-F) . 16 Astrocyte density was significantly higher in mVBI cases (Fig 4B; mVBI: 
Premyelinating OPCs Accumulate in mVBI Lesions
We previously reported that mVBI lesions displayed an increase in cells labeled with Olig2, 13 a marker of all OL lineage stages. To determine whether this increase is related to expansion of the OPC pool, we quantified the OPC marker, PDGFRa (Fig 5A-C) . The mVBI group displayed a significant increase in OPC density (Fig 5D; no VBI: 48,403 6 5,293; mVBI: 87,341 6 9,257; p 5 0.0024).
To determine whether the increase in OPCs in the mVBI group is related to WMI, we analyzed for associations between the density of OPCs and that of astrocytes or microglia. The density of PDGFRa 1 OPCs displayed a trend toward a significant association with astrocyte density for the mVBI group (Fig 5E; r 5 0.395; p 5 0.077; n 5 21), but there was no significant association with microglia density (Fig 5F; r 5 0.196; p 5 0.396; n 5 21).
Reduced Mature Oligodendrocytes in mVBI Lesions
We determined the effect of WMI on OPC maturation to OLs. To quantify OL somata, we first visualized the OL marker, CC1, 19 which not only detected numerous OL somata in controls, but also labeled numerous astrocytes in mVBI lesions. We next evaluated the mature-OL marker, Nogo-A. 20 We confirmed the selectivity of Nogo-A for mature-OL somata (Fig 6A) 20 and detected no labeling of astrocytes or microglia. When we quantified Nogo-A-labeled somata, the mVBI group exhibited a significant reduction in density ( Fig  6B; no VBI: 171,603 6 9,689; mVBI: 131,785 6 9,669; p 5 0.0078).
To determine whether the decrease in mature-OLs in the mVBI group was a response to WMI, we analyzed for an association between mature-OL and astrocyte or microglia density. Nogo-A-labeled mature-OLs were significantly negatively associated with astrocyte density for the mVBI group (Fig 6C; r 5 -0.505; p 5 0.0196; n 5 21), but there was no significant association with microglia density (Fig  6D; r 5 0.1923; p 5 0.2612; n 5 36).
OPC and Mature Oligodendrocyte Density Are Negatively Associated
To determine whether the decrease in OLs was related to the increase in OPCs in the mVBI group, we determined how OPC density was associated with mature-OL density. The mVBI group, but not the no VBI, displayed a significant negative association between OPC and OL density across the entire cohort (r 5 -0.4507; p 5 0.0058; n 5 36) and for the mVBI group alone ( Fig  6E; r 5 -0.447; p 5 0.042).
Discussion
Our findings support a model (Fig 7) in which selective vasodilator dysfunction of WM-penetrating arterioles in mVBI results in WMI. We previously reported that mVBI is accompanied by significant oxidative stress and MRI diffusion abnormalities that involve axons and myelin. 13 A consequence of WMI is reactive gliosis that involves astrocytes and microglia. In response to WMI, OPCs proliferate, but fail to differentiate to myelinating OLs. Diffuse WMI in preterm neonates 21 and older adults 13 similarly appears to involve OPC maturation arrest as well as aberrant remodeling of the extracellular matrix with accumulation of astrocyte-derived inhibitory forms of hyaluronic acid that block OPC maturation. [22] [23] [24] Future studies are needed to further define these and other related molecular pathways that impede WM regeneration and repair in VCID.
We found that human mVBI involves an unexpected imbalance in vascular reactivity between pial and WM microvessels. Whereas previous human cerebrovascular reactivity studies focused on larger caliber vessels such as the middle cerebral 8, 9 and pial arteries, 12 we FIGURE 7: Summary diagram illustrating vascular, cellular, and molecular mechanisms that appear to contribute to the pathogenesis of OPC maturation arrest in VCID. We propose that vasomotor dysfunction of WM penetrating arterioles results in hypoxia, ischemia, inflammation, and oxidative/nitrosative stress that contribute to axon and myelin damage. Additional axon degeneration also may arise from focal or diffuse retrograde degeneration from stroke. WMI triggers reactive microgliosis (Iba1 1 ) and astrogliosis (GFAP analyzed WM-arteriolar dysfunction. Although pial arterioles displayed no defects in vascular reactivity, WM arterioles displayed impaired reactivity to the endothelium-dependent agonist, ACh. Given that pial arterioles regulate downstream changes in local WM flow, 1 our results suggest that additional compromise of pial arteriolar blood flow in VCID may further disrupt flow to intrinsically less reactive WM arterioles. The predilection for WMI thus appears to involve dysregulation of blood flow at the level of penetrating WM arterioles. The mechanisms that contribute to selectively decreased vascular reactivity of WM-arterioles are unclear. Transgenic mice overexpressing amyloid precursor protein display pronounced disturbances in cerebral autoregulation. 10 Despite evidence from experimental models that AD contributes to VCID pathogenesis, our studies support that human vasodilator dysfunction can occur with low AD and primary mVBI. Endothelial synthesis of vasodilator nitric oxide (NO) by the endothelial NO synthase is central to ACh-induced dilation of cerebral arteries 25 and plays key roles in cerebrovascular regulation related to cognitive impairment. 26 NAD(P)H oxidases are one important source of superoxide anion production, which interferes with NO-mediated vasodilation and thus contributes to the development of cerebrovascular dysfunction in transgenic mice that overexpress amyloid precursor protein. 27, 28 Consistent with a role for vasodilator dysfunction in mVBI, we previously found a significant elevation in WM oxidative stress in VCID, independent of the burden of AD, but associated with aberrant accumulation of OL lineage cells in WM lesions. 13 Analysis of myelination in chronic WMI in VCID has been limited to descriptive studies with classical myelin stains (eg, Bodian; Luxol Fast Blue) 29 21 which suggests a common response to WMI in both the preterm and aging brain. Hypoxia-ischemia triggers a spectrum of preterm WMI that ranges from focal necrosis to diffuse non-necrotic lesions. 32 Whereas myelination failure in necrotic lesions involves axonal and glial degeneration, non-necrotic WMI generates milder diffuse injury where OPC maturation arrest predominates. 31 Similarly, micro or macro infarcts were uncommon in the frontal diffuse WM lesions in our VCID cases. Hence, in cases where mVBI predominates, WMI appears to involve diffuse, nonnecrotic lesions accompanied by OPC maturation arrest. Our study underscores the challenges and limitations to analyze the independent contribution of mVBI to VCID. Given that there are no reliable tissue biomarkers for mVBI, the extent of mVBI in each case was defined by neuropathological criteria. Diagnosis of mVBI was based upon cerebral microinfarcts that were not necessarily in prefrontal WM and were likely to be variable across the brain in terms of injury burden and chronicity. Nevertheless, our findings support that diffuse mVBI commonly occurs in prefrontal WM, but may not be identified without application of quantitative stereological approaches.
The sensitivity of MRI to detect diffuse WMI arising mostly from mVBI is unclear. We previously analyzed frontal WM lesions by diffusion-based ex vivo high-field magnetic resonance imaging (MRI) and found that mVBI lesions with low AD displayed no abnormalities, whereas a significant loss of fractional anisotropy was restricted to cases with mVBI and high AD pathology. 13 Although MRI-defined WM hyperintensities are commonly detected in periventricular as well as frontal WM, the pathological features of these lesions remain poorly defined. 29, 33 Future studies are needed to define the spectrum of pathology associated with MRI-defined hyperintensities and the extent to which they involve myelination failure related to OPC maturation arrest.
